Search





Search





Viking Therapeutics Inc

VKTX

Add to Watchlist

29.950USD

-1.580-5.01%

Close 09-15 16:00（ET）

3.49BMarket Cap

LossP/E TTM

Viking Therapeutics Inc

29.950

-1.580-5.01%

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

VKTX Cash Flow Statement

You can access the annual and quarterly cash flow statements of Viking Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q2

FY2015Q1

FY2014Q4

FY2014Q3

FY2014Q2

FY2014Q1

FY2013Q2

FY2013Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-165.98%-125.17M

-117.80%-113.98M

-173.53%-85.29M

-328.03%-94.00M

-65.05%-47.06M

-753.13%-52.33M

-76.76%-31.18M

-11.72%-21.96M

-149.35%-28.51M

75.11%-6.13M

-61.45%-17.64M

-45.63%-19.66M

14.93%-11.44M

-134.03%-24.64M

11.53%-10.93M

-23.55%-13.50M

-0.06%-13.44M

3.18%-10.53M

-125.12%-12.35M

-105.26%-10.93M

-101.53%-13.43M

-152.81%-10.88M

53.28%-5.49M

-56.65%-5.32M

-3.20%-6.67M

-36.48%-4.30M

-338.34%-11.74M

38.25%-3.40M

-22.56%-6.46M

40.56%-3.15M

32.14%-2.68M

-65.35%-5.50M

-25.38%-5.27M

-61.75%-5.30M

-60.17%-3.95M

-25.38%-3.33M

-30.26%-4.20M

-20.31%-3.28M

25.29%-2.46M

21.94%-2.65M

-99.10%-3.23M

-563.14%-2.73M

-648.22%-3.30M

-457.61%-3.40M

-268.45%-1.62M

-307.81%-410.94K

---440.97K

---609.82K

-4335.93%-439.87K

---100.77K

---9.92K

--0.00

Net income from continuing operations

-95.27%-128.02M

-246.98%-158.32M

-345.16%-157.66M

-264.02%-90.79M

-194.66%-65.56M

-66.80%-45.63M

-43.94%-35.42M

-10.68%-24.94M

-15.73%-22.25M

-40.06%-27.36M

-25.80%-24.61M

-42.86%-22.53M

-10.29%-19.23M

-21.29%-19.53M

-58.30%-19.56M

-19.10%-15.77M

-13.33%-17.43M

-14.94%-16.10M

-12.86%-12.36M

-42.58%-13.24M

-60.69%-15.38M

-44.63%-14.01M

-46.95%-10.95M

-62.07%-9.29M

-24.73%-9.57M

-96.73%-9.69M

-42.18%-7.45M

13.17%-5.73M

-15.02%-7.67M

-38.67%-4.92M

-28.29%-5.24M

-8.20%-6.60M

-29.01%-6.67M

32.00%-3.55M

-12.07%-4.08M

-60.20%-6.10M

-40.05%-5.17M

-45.58%-5.22M

28.41%-3.64M

19.62%-3.81M

53.05%-3.69M

37.20%-3.59M

-466.43%-5.09M

-1709.22%-4.74M

65.48%-7.87M

-2394.71%-5.71M

--1.39M

---261.80K

-101495.49%-22.78M

-4895.44%-228.94K

---22.43K

---4.58K

Operating gains losses

----

49.33%112.00K

50.00%111.00K

48.65%110.00K

19.18%87.00K

2.74%75.00K

2.78%74.00K

-48.59%73.00K

--73.00K

-6.49%72.00K

-5.26%72.00K

89.33%142.00K

-100.00%0.00

6.94%77.00K

7.04%76.00K

7.14%75.00K

7.35%73.00K

5.88%72.00K

-72.69%71.00K

--70.00K

--68.00K

--260.00K

----

Other non-cash items

72.54%-617.00K

61.05%-1.21M

58.63%-1.65M

61.61%-1.90M

58.46%-2.25M

-11.31%-3.10M

-49.89%-4.00M

-57.87%-4.95M

-181.28%-5.41M

-697.71%-2.78M

-7978.79%-2.67M

-1706.67%-3.13M

-510.02%-1.92M

-150.87%-349.00K

-104.30%-33.00K

-79.23%195.00K

-55.96%469.00K

-41.07%686.00K

-39.56%767.00K

-15.02%939.00K

20.89%1.06M

68.45%1.16M

131.57%1.27M

449.75%1.10M

88200.00%881.00K

996.83%691.00K

552.38%548.00K

125.84%201.00K

-100.21%-1.00K

108.02%63.00K

310.44%84.00K

-94.73%89.00K

-15.20%478.00K

-342.08%-786.00K

134.55%20.47K

194.40%1.69M

277.12%563.66K

-7.91%324.68K

-111.36%-59.24K

14.35%573.54K

-97.13%149.46K

-93.24%352.58K

129.36%521.56K

965.41%501.57K

8844.60%5.21M

31263.50%5.22M

---1.78M

--47.08K

1167.40%58.27K

1449.67%16.63K

--4.60K

--1.07K

Change in working capital

-206.00%-7.64M

333.83%35.22M

2566.08%65.48M

-737.50%-8.64M

189.90%7.20M

-194.43%-15.06M

-55.16%2.46M

-170.93%-1.03M

-259.62%-8.01M

289.80%15.95M

-15.48%5.48M

48600.00%1.46M

298.73%5.02M

-442.60%-8.40M

385.46%6.48M

98.99%-3.00K

284.60%1.26M

664.17%2.45M

-173.08%-2.27M

-122.53%-296.00K

-312.46%-682.00K

-89.21%321.00K

151.11%3.11M

-0.98%1.31M

9.18%321.00K

342.20%2.98M

-428.84%-6.08M

414.34%1.33M

0.34%294.00K

142.70%673.00K

845.66%1.85M

-65.09%258.00K

361.06%293.00K

-229.56%-1.58M

-128.15%-247.84K

185.86%738.99K

136.57%63.55K

1155.21%1.22M

18.56%880.39K

10.99%258.52K

60.48%-173.75K

-236.50%-115.28K

1457.03%742.57K

158.45%232.93K

-101.97%-439.62K

-23.67%84.45K

---54.72K

---398.50K

312432.92%22.28M

4247.39%110.64K

--7.13K

--2.54K

-Change in prepaid expenses

-110.96%-10.74M

148.44%4.63M

848.70%14.28M

-77.20%-4.83M

-6341.77%-5.09M

-646.57%-9.55M

2694.83%1.50M

-298.69%-2.73M

-101.07%-79.00K

177.41%1.75M

95.95%-58.00K

66.83%1.37M

388.95%7.35M

-9917.39%-2.26M

-366.45%-1.43M

-34.37%823.00K

-82.76%-2.54M

108.65%23.00K

-374.11%-307.00K

206.63%1.25M

-320.25%-1.39M

-146.75%-266.00K

101.68%112.00K

-572.00%-1.18M

203.61%632.00K

658.67%569.00K

-495.61%-6.67M

59.02%-175.00K

43.52%-610.00K

123.73%75.00K

750.38%1.69M

-273.91%-427.00K

-544.84%-1.08M

-242.79%-316.00K

9.42%198.26K

126.87%245.53K

17.82%-167.48K

17.90%221.31K

-57.29%181.20K

111.86%108.23K

64.62%-203.80K

1306.01%187.70K

40659.75%424.25K

-8286.92%-912.43K

-2720.09%-576.03K

-107.52%-15.56K

---1.05K

--11.14K

-1248.25%-20.43K

---7.50K

---1.51K

--0.00

-Change in other current assets

1190.91%120.00K

-62.11%936.00K

163.93%413.00K

63.62%2.20M

92.99%-11.00K

277.10%2.47M

-539.60%-646.00K

447.56%1.35M

-134.33%-157.00K

169.55%655.00K

-187.83%-101.00K

62.91%246.00K

-127.57%-67.00K

131.43%243.00K

-80.64%115.00K

1472.73%151.00K

-67.98%243.00K

163.25%105.00K

-11.74%594.00K

-100.57%-11.00K

--759.00K

---166.00K

--673.00K

--1.92M

----

--0.00

----

151.32%40.66K

----

---79.22K

----

---189.59K

---775.00

--0.00

Cash from non-recurring investing activities

Cash from operating activities

-165.98%-125.17M

-117.80%-113.98M

-173.53%-85.29M

-328.03%-94.00M

-65.05%-47.06M

-753.13%-52.33M

-76.76%-31.18M

-11.72%-21.96M

-149.35%-28.51M

75.11%-6.13M

-61.45%-17.64M

-45.63%-19.66M

14.93%-11.44M

-134.03%-24.64M

11.53%-10.93M

-23.55%-13.50M

-0.06%-13.44M

3.18%-10.53M

-125.12%-12.35M

-105.26%-10.93M

-101.53%-13.43M

-152.81%-10.88M

53.28%-5.49M

-56.65%-5.32M

-3.20%-6.67M

-36.48%-4.30M

-338.34%-11.74M

38.25%-3.40M

-22.56%-6.46M

40.56%-3.15M

32.14%-2.68M

-65.35%-5.50M

-25.38%-5.27M

-61.75%-5.30M

-60.17%-3.95M

-25.38%-3.33M

-30.26%-4.20M

-20.31%-3.28M

25.29%-2.46M

21.94%-2.65M

-99.10%-3.23M

-563.14%-2.73M

-648.22%-3.30M

-457.61%-3.40M

-268.45%-1.62M

-307.81%-410.94K

---440.97K

---609.82K

-4335.93%-439.87K

---100.77K

---9.92K

--0.00

Investing cash flow

Net cash flow from investment products

157.45%109.43M

-14.32%54.19M

1048.42%75.61M

517.83%160.03M

133.72%42.51M

113.76%63.24M

-81.57%6.58M

306.65%25.90M

38.35%-126.06M

-21018.65%-459.79M

392.19%35.73M

-146.61%-12.53M

-1177.36%-204.48M

35.76%2.20M

-73.51%7.26M

97.50%26.89M

433.15%18.98M

124.43%1.62M

-9.45%27.41M

241.34%13.62M

-63.60%3.56M

-159.42%-6.63M

373.66%30.27M

-163.57%-9.63M

-10.92%9.78M

246.56%11.15M

92.23%-11.06M

155.95%15.15M

116.48%10.98M

74.32%-7.61M

-3139.49%-142.39M

-2046.07%-27.09M

-8613.22%-66.63M

-1553.31%-29.63M

-403.72%-4.40M

215.59%1.39M

84.17%-764.64K

-65.87%2.04M

-26.01%1.45M

113.56%441.03K

60.32%-4.83M

--5.97M

--1.96M

---3.25M

---12.17M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

157.45%109.43M

-14.32%54.19M

1048.42%75.61M

517.83%160.03M

133.72%42.51M

113.76%63.24M

-81.57%6.58M

306.65%25.90M

38.35%-126.06M

-21018.65%-459.79M

392.19%35.73M

-146.61%-12.53M

-1177.36%-204.48M

35.76%2.20M

-73.51%7.26M

97.50%26.89M

433.15%18.98M

124.43%1.62M

-9.45%27.41M

241.34%13.62M

-63.60%3.56M

-159.42%-6.63M

373.66%30.27M

-163.57%-9.63M

-10.92%9.78M

246.56%11.15M

92.23%-11.06M

155.95%15.15M

116.48%10.98M

74.32%-7.61M

-3139.49%-142.39M

-2046.07%-27.09M

-8613.22%-66.63M

-1553.31%-29.63M

-403.72%-4.40M

215.59%1.39M

84.17%-764.64K

-65.87%2.04M

-26.01%1.45M

113.56%441.03K

60.32%-4.83M

--5.97M

--1.96M

---3.25M

---12.17M

----

Financing cash flow

Cash flow from continuous financing activities

4552.07%23.59M

3360.46%12.08M

7410.30%75.10M

-80.97%480.00K

-82.55%507.00K

-99.94%349.00K

431.91%1.00M

3508.11%2.52M

-98.91%2.91M

14384.63%606.04M

-98.25%188.00K

-840.00%-74.00K

16897.36%267.08M

183.58%4.18M

22770.21%10.75M

103.91%10.00K

-183.77%-1.59M

-196.44%-5.01M

-89.87%47.00K

-791.89%-256.00K

356.25%1.90M

15630.30%5.19M

102.62%464.00K

-49.32%37.00K

60.00%416.00K

-89.85%33.00K

-33.24%229.00K

-99.96%73.00K

-99.63%260.00K

-99.48%325.00K

-97.68%343.00K

14980.78%167.49M

1652.67%70.15M

2368.66%62.30M

1321.96%14.76M

925.01%1.11M

-56.77%4.00M

4503.88%2.52M

3785.10%1.04M

115.38%108.35K

-59.68%9.26M

-219.97%-57.30K

-107.00%-28.18K

-237.42%-704.66K

1733.53%22.96M

-895350.00%-17.91K

--402.41K

--512.76K

481.60%1.25M

---2.00

--215.35K

--0.00

Net cash flow from debt Issuance/repayment

----

--0.00

----

--0.00

100.00%0.00

---3.93M

----

--0.00

---77.26K

100.00%0.00

----

--0.00

---94.86K

----

-100.00%0.00

----

--500.00K

--750.00K

480.45%1.25M

--0.00

--215.35K

--0.00

Net cash flow from common stock issuance/repurchase

----

--0.00

100.00%0.00

--0.00

---1.67M

---5.12M

----

--0.00

-100.00%0.00

----

-100.00%0.00

13116.40%165.21M

1695.32%72.58M

2216.24%58.82M

1215.46%14.52M

137.75%1.25M

-59.24%4.04M

--2.54M

--1.10M

--525.77K

-60.94%9.92M

----

--0.00

100.00%0.00

1017226.20%25.39M

100.00%0.00

--0.00

---2.00

49820.00%2.50K

---2.00

--5.00

--0.00

Proceeds from stock option exercised by employees

99.80%1.01M

28.94%450.00K

15.50%1.16M

-80.97%480.00K

-82.70%507.00K

-92.00%349.00K

431.91%1.00M

252300.00%2.52M

12.05%2.93M

9.96%4.36M

25.33%188.00K

---1.00K

3013.10%2.62M

545.93%3.97M

127.27%150.00K

-100.00%0.00

-95.57%84.00K

-89.16%614.00K

-85.78%66.00K

-97.57%5.00K

329.41%1.90M

3440.00%5.66M

76.43%464.00K

46.10%206.00K

48.32%442.00K

-60.88%160.00K

-59.66%263.00K

-94.36%141.00K

-81.62%298.00K

-88.71%409.00K

3.79%652.00K

--2.50M

8166.61%1.62M

--3.62M

5437.07%628.18K

--0.00

79.19%19.61K

----

-44.63%11.35K

--0.00

408.50%10.94K

----

--20.49K

--0.00

--2.15K

----

Net cash flow from other financing activities

--22.57M

--11.63M

--73.95M

--0.00

----

--0.00

100.00%0.00

-100.01%-25.00K

275898.17%601.68M

-100.00%0.00

-830.00%-73.00K

--264.46M

143.69%218.00K

55884.21%10.60M

103.83%10.00K

--0.00

-5.50%-499.00K

---19.00K

-54.44%-261.00K

100.00%0.00

-272.44%-473.00K

100.00%0.00

-148.53%-169.00K

31.58%-26.00K

-51.19%-127.00K

89.00%-34.00K

68.81%-68.00K

68.33%-38.00K

42.47%-84.00K

19.51%-309.00K

-250.75%-218.00K

-100.25%-120.00K

-813.07%-146.00K

-399.65%-383.90K

85.11%-62.15K

89.59%-59.93K

72.10%-15.99K

-57.89%-76.83K

40.76%-417.42K

76.30%-575.71K

-219.97%-57.30K

50.14%-48.66K

-197.02%-704.66K

-121482350.00%-2.43M

---17.91K

---97.59K

---237.24K

--2.00

----

Net cash from non-recurrent financing activities

Net cash from financing activities

4552.07%23.59M

3360.46%12.08M

7410.30%75.10M

-80.97%480.00K

-82.55%507.00K

-99.94%349.00K

431.91%1.00M

3508.11%2.52M

-98.91%2.91M

14384.63%606.04M

-98.25%188.00K

-840.00%-74.00K

16897.36%267.08M

183.58%4.18M

22770.21%10.75M

103.91%10.00K

-183.77%-1.59M

-196.44%-5.01M

-89.87%47.00K

-791.89%-256.00K

356.25%1.90M

15630.30%5.19M

102.62%464.00K

-49.32%37.00K

60.00%416.00K

-89.85%33.00K

-33.24%229.00K

-99.96%73.00K

-99.63%260.00K

-99.48%325.00K

-97.68%343.00K

14980.78%167.49M

1652.67%70.15M

2368.66%62.30M

1321.96%14.76M

925.01%1.11M

-56.77%4.00M

4503.88%2.52M

3785.10%1.04M

115.38%108.35K

-59.68%9.26M

-219.97%-57.30K

-107.00%-28.18K

-237.42%-704.66K

1733.53%22.96M

-895350.00%-17.91K

--402.41K

--512.76K

481.60%1.25M

---2.00

--215.35K

--0.00

Net cash flow

Beginning cash balance

211.32%118.12M

521.57%165.81M

99.37%100.38M

-22.85%33.88M

-80.60%37.94M

-51.95%26.68M

35.40%50.35M

-36.83%43.91M

965.13%195.58M

51.55%55.52M

26.45%37.19M

328.44%69.52M

47.44%18.36M

38.91%36.63M

161.08%29.41M

83.78%16.23M

-25.89%12.45M

-9.43%26.37M

191.06%11.26M

-53.01%8.83M

10.12%16.80M

247.58%29.12M

-87.50%3.87M

-1.74%18.79M

6.39%15.26M

-66.19%8.38M

-81.74%30.95M

-44.75%19.12M

-60.55%14.34M

175.69%24.78M

6500.54%169.51M

919.85%34.61M

734.04%36.36M

192.24%8.99M

-15.94%2.57M

-34.23%3.39M

10.11%4.36M

300.17%3.08M

42.74%3.05M

-45.67%5.16M

1110.60%3.96M

1.68%768.55K

169.40%2.14M

965.33%9.50M

314.73%327.01K

320.81%755.86K

--794.41K

--891.48K

--78.85K

--179.62K

--0.00

Current period cash flow changes

293.23%7.84M

-523.42%-47.69M

376.43%65.43M

933.83%66.50M

97.32%-4.06M

-91.96%11.26M

-229.13%-23.67M

119.89%6.43M

-396.47%-151.66M

866.63%140.06M

153.75%18.33M

-345.29%-32.33M

1256.23%51.16M

-31.28%-18.27M

-52.18%7.22M

441.36%13.18M

147.29%3.77M

-13.04%-13.92M

-40.16%15.11M

116.32%2.44M

-325.95%-7.98M

-278.88%-12.31M

211.84%25.25M

-226.13%-14.92M

-26.15%3.53M

165.95%6.88M

84.40%-22.57M

-91.23%11.83M

373.77%4.78M

-138.13%-10.44M

-2354.17%-144.73M

16439.38%134.90M

-80.86%-1.75M

2032.22%27.37M

31051.94%6.42M

60.78%-825.59K

-180.37%-965.39K

-59.77%1.28M

101.50%20.61K

71.39%-2.11M

-86.90%1.20M

843.90%3.19M

-3457.15%-1.37M

-7479.54%-7.36M

1028.46%9.17M

-325.57%-428.85K

---38.56K

---97.06K

295.56%812.63K

---100.77K

--205.44K

--0.00

Effect of exchange rate changes

100.00%0.00

1500.00%16.00K

112.16%9.00K

79.31%-6.00K

-500.00%-12.00K

102.08%1.00K

-248.00%-74.00K

57.35%-29.00K

200.00%3.00K

-433.33%-48.00K

-64.54%50.00K

69.51%-68.00K

98.30%-3.00K

---9.00K

--141.00K

---223.00K

---176.00K

----

Ending cash balance

271.79%125.96M

211.32%118.12M

521.57%165.81M

99.37%100.38M

-22.85%33.88M

-80.60%37.94M

-51.95%26.68M

35.40%50.35M

-36.83%43.91M

965.13%195.58M

51.55%55.52M

26.45%37.19M

328.44%69.52M

47.44%18.36M

38.91%36.63M

161.08%29.41M

83.78%16.23M

-25.89%12.45M

-9.43%26.37M

191.06%11.26M

-53.01%8.83M

10.12%16.80M

247.58%29.12M

-87.50%3.87M

-1.74%18.79M

6.39%15.26M

-66.19%8.38M

-81.74%30.95M

-44.75%19.12M

-60.55%14.34M

175.68%24.78M

6500.54%169.51M

919.85%34.61M

734.04%36.36M

192.26%8.99M

-15.94%2.57M

-34.23%3.39M

10.11%4.36M

300.17%3.08M

42.74%3.05M

-45.67%5.16M

1110.60%3.96M

1.68%768.55K

169.40%2.14M

965.33%9.50M

314.73%327.01K

--755.86K

--794.41K

333.94%891.48K

--78.85K

--205.44K

--0.00

Free cash flow

-165.98%-125.17M

-117.80%-113.98M

-173.53%-85.29M

-328.03%-94.00M

-65.05%-47.06M

-753.13%-52.33M

-76.76%-31.18M

-11.72%-21.96M

-149.35%-28.51M

75.11%-6.13M

-61.45%-17.64M

-45.63%-19.66M

14.93%-11.44M

-134.03%-24.64M

11.53%-10.93M

-23.55%-13.50M

-0.06%-13.44M

3.18%-10.53M

-125.12%-12.35M

-105.26%-10.93M

-101.53%-13.43M

-152.81%-10.88M

53.28%-5.49M

-56.65%-5.32M

-3.20%-6.67M

-36.48%-4.30M

-338.34%-11.74M

38.25%-3.40M

-22.56%-6.46M

40.56%-3.15M

32.14%-2.68M

-65.35%-5.50M

-25.38%-5.27M

-61.75%-5.30M

-60.17%-3.95M

-25.38%-3.33M

-30.26%-4.20M

-20.31%-3.28M

25.29%-2.46M

21.94%-2.65M

-99.10%-3.23M

---2.73M

---3.30M

---3.40M

---1.62M

----

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Viking Therapeutics Inc Generate?



Viking Therapeutics Inc generated -278.69M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Viking Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Viking Therapeutics Inc's operating cash flow increased by -217.45% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Viking Therapeutics Inc's Financing Cash Flow Changed?



Viking Therapeutics Inc used 76.44M in financing activities in the latest quarter.

What is free cash flow and why does it matter for VKTX?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Viking Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -278.69M reflecting a -217.45% change from the previous year.